NEUBASE THERAPEUTICS INC (NBSE) Stock Analyst Earnings Estimates
NASDAQ:NBSE - Nasdaq - US64132K2015 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | ||||||||||
| EBITDA YoY % growth | -8.65M | -16.29M -88.32% | -23.41M -43.71% | -22.61M 3.42% | -7.95M 64.84% | -25.38M -219.25% | -16.79M 33.85% | -26.17M -55.87% | -32.55M -24.38% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.12M | -17.47M -91.56% | -24.59M -40.76% | -23.78M 3.29% | -9.07M 61.86% | -25.51M -181.26% | -17.07M 33.09% | -26.57M -55.65% | -33.32M -25.40% | N/A 57.12% | N/A -35.65% | N/A -31.58% | N/A 18.00% | N/A -21.95% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -8.20 | -10.60 -29.27% | -16.80 -58.49% | N/A 30.79% | N/A | N/A | -0.89 96.58% | -0.92 -3.37% | -16.24 -1,665.22% | -7.30 55.05% | N/A -25.75% | N/A -26.67% | N/A 86.23% | N/A -17.83% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -0.66 86.25% | -1.86 | 1.20 | 64.45% |
| Q3 2023 Q2Q % growth | -2.04 60.77% | -2.04 | 0.00 | 0.00% |
| Q2 2023 Q2Q % growth | -2.40 60.00% | -2.35 | -0.05 | -2.30% |
| Q1 2023 Q2Q % growth | -2.20 -816.67% | -3.16 | 0.96 | 30.42% |
| Q4 2022 Q2Q % growth | -4.80 -2,185.71% | -5.64 | 0.84 | 14.95% |
| Q3 2022 Q2Q % growth | -5.20 -1,693.10% | -6.05 | 0.85 | 14.08% |
| Q2 2022 Q2Q % growth | -6.00 -2,400.00% | -4.62 | -1.38 | -29.76% |
| Q1 2022 Q2Q % growth | -0.24 -33.33% | -0.23 | -0.01 | -2.30% |
| Q4 2021 Q2Q % growth | -0.21 -10.53% | -0.23 | 0.02 | 10.49% |
| Q3 2021 Q2Q % growth | -0.29 -61.11% | -0.21 | -0.08 | -35.39% |
| Q2 2021 Q2Q % growth | -0.24 7.69% | -0.22 | -0.02 | -6.95% |
| Q1 2021 Q2Q % growth | -0.18 30.77% | -0.23 | 0.05 | 23.27% |
| Q4 2020 Q2Q % growth | -0.19 91.12% | -0.20 | 0.01 | 6.08% |
| Q3 2020 Q2Q % growth | -0.18 | -0.23 | 0.05 | 22.15% |
| Q2 2020 Q2Q % growth | -0.26 | -0.23 | -0.03 | -14.56% |
| Q1 2020 Q2Q % growth | -0.26 | -0.32 | 0.06 | 19.72% |
| Q4 2019 Q2Q % growth | -2.14 | -0.28 | -1.86 | -658.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |